000 01539 a2200433 4500
005 20250516022027.0
264 0 _c20111212
008 201112s 0 0 eng d
022 _a1539-6304
024 7 _a10.2500/aap.2011.32.3404
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBernstein, Jonathan A
245 0 0 _aHereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensity.
_h[electronic resource]
260 _bAllergy and asthma proceedings
_c
300 _a36-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngioedemas, Hereditary
_xdrug therapy
650 0 4 _aComplement C1 Inhibitor Protein
_xadministration & dosage
650 0 4 _aEndpoint Determination
650 0 4 _aHumans
650 0 4 _aKaplan-Meier Estimate
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
700 1 _aRitchie, Bruce
700 1 _aLevy, Robyn J
700 1 _aWasserman, Richard L
700 1 _aBewtra, Againdra K
700 1 _aHurewitz, David S
700 1 _aObtułowicz, Krystyna
700 1 _aReshef, Avner
700 1 _aMoldovan, Dumitru
700 1 _aShirov, Todor
700 1 _aGrivcheva-Panovska, Vesna
700 1 _aKiessling, Peter C
700 1 _aKeinecke, Heinz-Otto
700 1 _aCraig, Timothy J
773 0 _tAllergy and asthma proceedings
_gvol. 32
_gno. 1
_gp. 36-42
856 4 0 _uhttps://doi.org/10.2500/aap.2011.32.3404
_zAvailable from publisher's website
999 _c20542941
_d20542941